Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib StudyFunda Meric‐Bernstam, Shahneen Sandhu, Stefan Kasper et al.|Clinical Cancer Research|2022Cited by 226
Meeting ReportVito G. Sasseville, L. J. Lowenstine, Keith G. Mansfield et al.|Veterinary Pathology|2012Cited by 15